DOCSLIB.ORG

AIDS and Social Policy in China

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
AIDS and Social Policy in China AIDS and Social Policy in China The Asia Public Policy Series The Asia Public Policy series seeks to promote interdisciplinary research on key challenges facing the region. Specifically the series focuses on the provision of public goods and services, the health of financial systems, and regional security. Tony Saich General Editor AIDS and Social Policy in China edited by Joan Kaufman, Arthur Kleinman, and Tony Saich Published by the Harvard University Asia Center Cambridge, Massachusetts, 2006 © 2006 by the President and Fellows of Harvard College Printed in the United States of America The Harvard University Asia Center publishes a monograph series and, in coordination with the Fairbank Center for East Asian Research, the Korea Institute, the Reischauer Institute of Japanese Studies, and other faculties and institutes, administers research projects designed to further scholarly understanding of China, Japan, Vietnam, Korea, and other Asian countries. The Center also sponsors projects addressing multidisciplinary and regional issues in Asia. Printed on acid-free paper Last figure below indicates year of this printing 16 15 14 13 12 11 10 09 08 07 06 Acknowledgments 7 The Michael Crichton Fund of the Department of Social Medicine at Harvard Medical School, Harvard University’s Provost Office, Asia Pro- grams of the Kennedy School’s Mossavar-Rahmani Center for Business and Government, Asia Center of Harvard University, and the Fairbank Center for East Asian Research of Harvard University generously funded the Social Policy and AIDS in China Conference, the 3rd Asia Public Policy Workshop, and the 4th W.H.R. Rivers Symposium. This volume’s publication was sup- ported by the Michael Crichton Fund, the Folger Fund and Lee Folger, and by the China AIDS Public Policy Training Project at the Kennedy School’s Mossavar-Rahmani Center for Business and Government. Special thanks are due to Kathrine Meyers for her assistance in all matters relating to the workshop and seminar series organization and management; to Marilyn Goodrich, Liz Meyer, Jennifer Moltoni, and Wu Fei for their help with lo- gistics; and to Kristin Eifler and Victoria R. M. Scott for their assistance in editing the volume. We also thank the anonymous reviewers for their con- structive comments and insights. The Editors Contents 7 Contributors ix Abbreviations xv Preface: A Biosocial Understanding of AIDS in China xix Paul Farmer I. Background and Policy 1 Introduction: Social Policy and HIV/AIDS in China 3 Joan Kaufman, Arthur Kleinman, and Tony Saich 2 Social Policy Development in the Era of Economic Reform 15 Tony Saich 3 AIDS Surveillance in China: Data Gaps and Research for AIDS Policy 47 Joan Kaufman and Kathrine Meyers II. Treatment 4 Controlling HIV/AIDS in China: Health System Challenges 75 Yuanli Liu and Joan Kaufman 5 Initiation of the National Free Antiretroviral Therapy Program in Rural China 96 Fujie Zhang, Michael Hsu, Lan Yu, Yi Wen, and Jennifer Pan 6 Access to HIV/AIDS Treatment in China: Intellectual Property Rights, Generics, and Barriers to Effective Treatment 125 Jean-François Dechamp and Odilon Couzin viii Contents 7 The Social Origin of AIDS Panics in China 152 Jun Jing 8 Perspectives on Stigma and the Needs of People Living with AIDS in China 170 Thomas Cai III. Prevention 9 Opportunity for Effective Prevention of AIDS in China: The Strategy of Preventing Secondary Transmission of HIV 177 Ray Yip 10 Sexual Partners in China: Risk Pattern for Infection by HIV and Possible Interventions 190 William L. Parish and Suiming Pan 11 A Delicate Balance: Law Enforcement Agencies and Harm Reduction Interventions for Injection Drug Users in China and Vietnam 214 Theodore M. Hammett, Yi Chen, Doan Ngu, Dao Dinh Cuong, Ly Kieu Van, Wei Liu, Meng Donghua, Hoang Ngoc Quyen, Robert S. Broadhead, and Don C. Des Jarlais 12 Youth and HIV/AIDS in China 232 Xiaomei Ru IV. Impact Mitigation 13 Children Affected by AIDS: Orphans and Impact Mitigation in China 243 Andy West and Kate Wedgwood Afterword 265 Contributors 7 Volume Co-editors Joan Kaufman Kennedy School of Government Joan Kaufman is a Lecturer in the Department of Social Medicine at Har- vard Medical School, Senior Scientist at the Heller School of Social Policy and Management at Brandeis University, and Director of the AIDS Public Policy Program at the Kennedy School of Government. The AIDS Public Policy Program seeks to build the capacity of government officials in de- veloping countries on the multi-sectoral requirements for implementation of HIV/AIDS policies and programs. The Program is now active in China and Vietnam. Arthur Kleinman Faculty of Arts and Sciences and Harvard Medical School Arthur Kleinman, a physician and anthropologist, is the Esther and Sidney Rabb Professor of Anthropology in the Faculty of Arts and Sciences, Harvard University, and Professor of Medical Anthropology and Psychiatry at Harvard Medical School. Kleinman is currently on the board of advisors of the Beijing Municipal Suicide Prevention Center and is collaborating with colleagues at Tsinghua University (Beijing) and the Chinese University of Hong Kong on several different research projects. Anthony Saich Kennedy School of Government Tony Saich is the Daewoo Professor of International Affairs; Director and Faculty Chair of Asia Programs and the China Public Policy Program at the Mossavar-Rahmani Center for Business and Government at the Kennedy School of Government, Harvard University; and Director of the Harvard x Contributors University Asia Center. His teaching and research focus on the interplay between the state and society in Asia and the respective roles they play in determining policymaking and framing socioeconomic development. He has written several books on the developments in China, including China: Politics and Government; Revolutionary Discourse in Mao’s China (with David E. Apter) and The Rise to Power of the Chinese Communist Party. Volume Contributors Thomas Cai AIDS Activist Mr. Cai is an HIV-positive activist from Guangdong province and has been working for four years in the field of providing care and support to people living with HIV/AIDS. With support from international NGOs and UNDP, in June 2002, Mr. Cai helped organize PLWA to promote greater awareness in China. Under Mr. Cai’s leadership, these individuals have become actively involved in advocacy and prevention efforts, as well as in providing care and support to the PLWA in Guangdong and Guangxi provinces. Odilon Couzin China AIDS Info Odilon Couzin is the Executive Director of China AIDS Info, an inde- pendent non-profit group based in Hong Kong. Couzin has spent the pre- vious decade living primarily in China; from 1993 to 1996 he studied Chinese in Kunming, the capital of Yunnan province. He has worked in a number of different capacities for NGOs in China and has been involved in projects ranging from emergency relief distribution to the planning of program strategies. Couzin resigned after three years of being a foreign correspon- dent in Beijing and founded China AIDS Info. Jean-François Dechamp Independent Consultant Jean-François Dechamp was the Co-ordinator of the European AIDS Treatment Group before being called by the European Commission to join the Ethics and Science Unit of the European Commission (Directorate General for Research) in September 2005. In 2002, he joined the humani- tarian aid organisation Médecins Sans Frontières / Doctors Without Borders (MSF), where he worked within the Campaign for Access to Essential Contributors xi Medicines. This was followed by a six-month mission to China where he worked on strengthening the HIV/AIDS treatment project team. Jean- François Dechamp graduated as a pharmacist from the University of Stras- bourg, France in 1991. Paul Farmer Department of Social Medicine Paul Farmer, MD, PhD, is a medical anthropologist whose work draws pri- marily on active clinical practice and focuses on diseases disproportionately afflicting the poor. He divides his clinical time between the Brigham and Women’s Hospital (Division of Infectious Disease), where he is an attending physician, and a charity hospital in rural Haiti, the Clinique Bon Sauveur, where he serves as medical co-director. An infectious disease physician as well as an anthropologist, Dr. Farmer has worked in communicable-disease control in the Americas for over a decade and is a world-renowned authority on tuberculosis treatment and control. Theodore Hammett Abt Associates Theodore M. Hammett, Ph.D. is a Vice President at Abt Associates Inc., a leading policy research firm with headquarters in Cambridge, Massachusetts. In his 24 years with Abt Associates, Dr. Hammett has focused on HIV/AIDS, in particular its relation to correctional and drug-using popu- lations. He is currently the principal investigator for a four-year cross-border HIV prevention project for injection drug users in China and Vietnam. This project is funded by the National Institute on Drug Abuse (NIDA) and the Ford Foundation. Jing Jun Tsinghua University Jing Jun holds a joint appointment in the Department of Sociology and the School of Public Policy at Tsinghua University in Beijing. He has been working on the HIV/AIDS epidemic in China as a social researcher and policy advocate and teaches a sociological course on AIDS and works as a policy advisor for the Chinese Ministry of Health. A native of Beijing, re- ceived his Ph.D. in social anthropology from Harvard University in 1994. xii Contributors Yuanli Liu Harvard School of Public Health Dr. Yuanli Liu is Assistant Professor of International Health at the Harvard School of Public Health (HSPH) and Director of the HSPH China Initiative, as well as Vice President of China Foundation, a US-based think tank. He was profiled by the HSPH 2003 Annual Report as one of six “Future Leaders in Public Health.” Dr. Liu received his graduate degrees in public health, health policy, and health economics from Tongji Medical University (1987), Harvard University (1988), and University of Minnesota (1995).
Load more

Recommended publications
  • Impact of Hepatitis B Virus Infection on HIV Response to Antiretroviral
    International Journal of Infectious Diseases 28 (2014) 29–34 Contents lists available at ScienceDirect International Journal of Infectious Diseases jou rnal homepage: www.elsevier.com/locate/ijid Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in a Chinese antiretroviral therapy center Rongrong Yang, Xien Gui *, Yong Xiong, Shi-cheng Gao, Yajun Yan Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan 430071, China A R T I C L E I N F O S U M M A R Y Article history: Background: Co-infection with hepatitis B virus (HBV) and HIV is common in China; however, the impact Received 9 April 2014 of HBV on long-term antiretroviral therapy (ART) outcomes has not been fully characterized. Received in revised form 17 July 2014 Methods: Patients were classified as being HIV mono-infected (hepatitis B surface antigen (HBsAg)- Accepted 25 July 2014 negative) or HIV/HBV co-infected (HBsAg-positive). The effects of HBV on HIV virological response, Corresponding Editor: Eskild Petersen, changes in CD4 cell counts, hepatotoxicity, and mortality among Chinese patients receiving ART were Aarhus, Denmark evaluated. Results: The HIV/HBV co-infection rate in our cohort was 9.9% (354/3562). Five hundred and fifty HIV Keywords: mono-infected and 78 HIV/HBV co-infected individuals fulfilled the inclusion criteria. HIV/HBV co- Hepatitis B virus infected individuals were less likely to achieve HIV-RNA suppression and a CD4 increase than HIV mono- Acquired immunodeficiency syndrome infected individuals at 48 months post-ART. Greater hepatotoxicity and a more rapid occurrence of death Human immunodeficiency virus were observed in HIV/HBV co-infected subjects.
    [Show full text]
  • Infectious Diseases in Children and Adolescents in China: Analysis BMJ: First Published As 10.1136/Bmj.M1043 on 2 April 2020
    RESEARCH Infectious diseases in children and adolescents in China: analysis BMJ: first published as 10.1136/bmj.m1043 on 2 April 2020. Downloaded from of national surveillance data from 2008 to 2017 Yanhui Dong,1 Liping Wang,2 David P Burgner,3,4 Jessica E Miller,3,4 Yi Song,1 Xiang Ren,2 Zhongjie Li,2 Yi Xing,1 Jun Ma,1 Susan M Sawyer,3,4,5 George C Patton3,4,5 For numbered affiliations see ABSTRACT 100 000 in 2008 to 162 per 100 000 in 2015, but rose end of the article. OBJECTIVES again to 242 per 100 000 in 2017, largely related to Correspondence to:J Ma To outline which infectious diseases in the pre- mumps and seasonal influenza. Excluding mumps [email protected] (ORCID 0000-0003-3529-1808) covid-19 era persist in children and adolescents in and influenza, the incidence of vaccine preventable Additional material is published China and to describe recent trends and variations by diseases fell from 96 per 100 000 in 2008 to 7 per online only. To view please visit age, sex, season, and province. 100 000 in 2017. The incidence of gastrointestinal the journal online. DESIGN and enterovirus diseases remained constant, but C ite this as: BMJ2020;369:m1043 National surveillance studies, 2008-17. typhoid, paratyphoid, and dysentery continued to http://dx.doi.org/10.1136 bmj.m1043 decline. Vectorborne diseases all declined, with a SETTING Accepted: 12 March 2020 particularly noticeable reduction in malaria. Zoonotic 31 provinces in mainland China. infections remained at low incidence, but there were PARTICIPANTS still unpredictable outbreaks, such as pandemic A/ 4 959 790 Chinese students aged 6 to 22 years with a H1N1 2009 influenza.
    [Show full text]
  • Combating Hepatitis B and C by 2030: Achievements, Gaps, and Options for Actions in China
    Analysis BMJ Glob Health: first published as 10.1136/bmjgh-2020-002306 on 30 June 2020. Downloaded from Combating hepatitis B and C by 2030: achievements, gaps, and options for actions in China 1 2 2 3 2 Shu Chen , Wenhui Mao , Lei Guo , Jiahui Zhang, Shenglan Tang To cite: Chen S, Mao W, Guo L, ABSTRACT Summary box et al. Combating hepatitis B China has the highest number of hepatitis B and C cases and C by 2030: achievements, globally. Despite remarkable achievements, China faces ► China has made considerable achievements in con- gaps, and options for actions daunting challenges in achieving international targets in China. BMJ Global Health trolling hepatitis B and C through multiple strategies for hepatitis elimination. As part of a large- scale project 2020;5:e002306. doi:10.1136/ with efforts focused on prevention and increased assessing China’s progress in achieving health- related bmjgh-2020-002306 treatment financing. Sustainable Development Goals using quantitative, ► Formidable challenges remain in combating hepati- qualitative data and mathematical modelling, this paper Handling editor Alberto L tis by 2030. Key health system barriers, including a summarises the achievements, gaps and challenges, Garcia- Basteiro fragmented governance system, insufficient funding, and proposes options for actions for hepatitis B and C inadequate service coverage and unstandardised Received 9 January 2020 control. China has made substantial progress in controlling treatment, and flawed information systems, have Revised 13 May 2020 chronic viral
    [Show full text]
  • Trichuris Trichiura
    Xiao et al. Parasites & Vectors (2015) 8:661 DOI 10.1186/s13071-015-1279-2 RESEARCH Open Access Prevalence and risk factors of Ascaris lumbricoides (Linnaeus, 1758), Trichuris trichiura (Linnaeus, 1771) and HBV infections in Southwestern China: a community-based cross sectional study Peng-Lei Xiao1,2,3, Yi-Biao Zhou1,2,3,6*, Yue Chen4, Ya Yang1,2,3, Yan Shi1,2,3, Jian-Chuan Gao1,2,3, Wu-Li Yihuo5, Xiu-Xia Song1,2,3 and Qing-Wu Jiang1,2,3 Abstract Background: Intestinal helminths do not cause severe diseases in general, however, when combined with other diseases such as immunodeficiency diseases, there would be massive complications. Infections with Hepatitis B Virus (HBV) may lead to immunological disturbances and defects of cellular immunity and there is a need of clarification whether HBV infections are associated with infections with intestinal helminths. Methods: A community-based cross sectional study was conducted in Tezi town, Puge County of the Liangshan Prefecture, southwestern China from October 23rd to November 3rd, 2014. Four hundred and thirty eight people (median age = 37 years, IQR = 22–49) were enrolled in this study. Modified Kato-Katz thick smear was used to detect intestinal helminths. HBV DNA was quantified to confirm HBV infection. Results: Among the 438 participants, 9.1 %, 13.5 % and 30.6 % were infected with HBV, A. lumbricoides (L., 1758) and T. trichiura (L., 1771), respectively; 7.1 % (30/438) were infected with both A. lumbricoides and T. trichiura and 2.3 % (10/438) were co-infected with HBV and A. lumbricoides. The multivariate logistic regression analysis showed that age (21–30 years versus >50 years: OR = 6.66, 95 % CI = 2.15–20.68), drug abuse (OR = 6.96, 95 % CI = 1.11– 43.90), A.
    [Show full text]
  • Global Hepatitis Report 2017 ISBN 978-92-4-156545-5 © World Health Organization 2017 Some Rights Reserved
    2017 REPORT, HEPATITIS GLOBAL TREAT TEST PREVENT GLOBAL HEPATITIS REPORT, 2017 Global hepatitis report 2017 ISBN 978-92-4-156545-5 © World Health Organization 2017 Some rights reserved. This work is available under the Creative Commons Attribution- NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/ licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non- commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specifi c organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders.
    [Show full text]
  • Countdown to 2030: Eliminating Hepatitis B Disease, China Jue Liu,A Wannian Liang,B Wenzhan Jinga & Min Liua
    Policy & practice Countdown to 2030: eliminating hepatitis B disease, China Jue Liu,a Wannian Liang,b Wenzhan Jinga & Min Liua Abstract Hepatitis B virus (HBV) infection is a major public health problem worldwide. China has the world’s largest burden of HBV infection and will be a major contributor towards the global elimination of hepatitis B disease by 2030. The country has made good progress in reducing incidence of HBV infection in the past three decades. The achievements are mainly due to high vaccination coverages among children and high coverage of timely birth-dose vaccine for prevention of mother-to-child transmission of HBV (both > 95%). However, China still faces challenges in achieving its target of 65% reduction in mortality from hepatitis B by 2030. Based on targets of the World Health Organization’s Global health sector strategy on viral hepatitis 2016–2021, we highlight further priorities for action towards HBV elimination in China. To achieve the impact target of reduced mortality we suggest that the service coverage targets of diagnosis and treatment should be prioritized. First, improvements are needed in the diagnostic and treatment abilities of medical institutions and health workers. Second, the government needs to reduce the financial burden of health care on patients. Third, better coordination is needed across existing national programmes and resources to establish an integrated prevention and control system that covers prevention, screening, diagnosis and treatment of HBV infection across the life cycle. In this way, progress can be made towards achieving the target of eliminating hepatitis B in China by 2030. Introduction Cochrane Library databases for English language articles and the China National Knowledge Infrastructure and Wanfang Hepatitis B virus (HBV) infection is a major public health databases for Chinese language articles.
    [Show full text]
  • Epidemiology of Hepatitis B Virus Infection in China: Current Status and Challenges
    Review Article Epidemiology of Hepatitis B Virus Infection in China: Current Status and Challenges Yong-Ping Yan, Hai-Xia Su, Zhao-Hua Ji, Zhong-Jun Shao and Zhong-Shu Pu Department of Epidemiology, and the Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, Fourth Military Medical University, Xi’an, Shaanxi, China Abstract including chronic hepatitis, hepatic cirrhosis, and even hepatocellular carcinoma. Chronic hepatitis B is associated The prevalence of hepatitis B is high in China. Based on the with approximately 90% and 30% of neonatal and childhood National Disease Supervision Information Management HBV infection, respectively, while less than 10% of adults System of China, the mean reported incidence of hepatitis B infected develop chronic hepatitis B.4 In China, hepatitis B is a was 84.3 per 100,000 in China between 2005 and 2010. There major disease that affects human health, often leading to are differences in population distribution based on region and chronic poverty because of it high prevalence, persistence, ethnic group. Here, risk factors, virological characteristics, and and difficult treatment. Therefore, controlling HBV infection prophylaxis of hepatitis B in China are reviewed. Although the has become a top priority for the Chinese government. This prevalence of HBV infection is gradually declining, there are review describes the epidemiology and prophylaxis of HBV many challenges in HBV infection control, including higher infection, as well as the challenges of hepatitis B control in prevalence in floating population, poor compliance of antiviral China. therapy, and high disease burden. E 2014 The Second Affiliated Hospital of Chongqing Medical The characteristics of notified incidence of hepatitis B University.
    [Show full text]
  • Consumer-Citizens of China
    Consumer-Citizens of China This book presents a comprehensive examination of Chinese consumer behaviour and challenges the previously dichotomous interpretation of the consumption of Western and non-Western brands in China. The dominant position is that Chinese consumers are driven by a desire to imitate the lifestyles of Westerners and thereby advance their social standing locally. The alternative is that consumers reject Western brands as a symbolic gesture of loyalty to their nation-state. Drawing from survey responses and in-depth interviews with Chinese consum- ers in both rural and urban areas, Kelly Tian and Lily Dong find that consumers situ- ate Western brands within select historical moments. This embellishment attaches historical meanings to Western brands in ways that render them useful in assert- ing preferred visions of the future China. By highlighting how Western brands are used in contests for national identity, Consumer-Citizens of China challenges the notion of the “patriot’s paradox” and answers scholars’ questions as to whether Chinese nationalists today allow for a Sino-Western space where the Chinese can love China without hating the West. Consumer-Citizens of China will be of interest to students and scholars of Business Studies, Chinese and Asian Studies, and Political Science. Kelly Tian is Professor of Marketing and holds the Anderson Chair of Business at New Mexico State University. Lily Dong is Associate Professor of Marketing at the University of Alaska Fairbanks. Routledge Contemporary China Series 1 Nationalism, Democracy and National Integration in China Leong Liew and Wang Shaoguang 2 Hong Kong’s Tortuous Democratization A comparative analysis Ming Sing 3 China’s Business Reforms Institutional challenges in a globalised economy Edited by Russell Smyth and Cherrie Zhu 4 Challenges for China’s Development An enterprise perspective Edited by David H.
    [Show full text]
  • China: Issues and Options in Health Financing
    ReportNo. 15278-CHA China: Issuesand Options in Health Public Disclosure Authorized Financing August12, 1996 Chlin, in Mn(N'loli(i Dep,irtmenelt I Ii111,1n I)evelOpmrnntDep,ilrillent Public Disclosure Authorized Public Disclosure Authorized Public Disclosure Authorized Documentof the World Bank Exchange Rate CuLrrencyUnit = Yuan (Y) 1993 US$1.00 = Y 8.0 (commercial rate) January, 1996 US$ 1.00= Y 8.3 (official rate) Note: Ulnlessotherwise specified, all yuan valueshave been adjustedto 1993 constantyuan. Acronyms CEM Country Economic Memorandumii(World Bank) CMS Rural Cooperative Medical System DALY Disability-adjusted Life Year DRG Diagnosis Related Grouips EPI Expanded Program on Immunization EPS Epidemic PreventionlService FP Family Plannilig and Reproductive HealthiProgram GBD Global Burden of Disease GIS Government Employees' Health Insurance System [also retirees, military, university studenits] HEI Health Economics Institute; sometimes called National Healthi Economics Researcih Institute HFA Health-for-All in the Year 2000 (Goal of the WHIO) IMR InfanitMortality Rate LIS Labor Health Insurance System (covers employees of state-owned enterprises) MCH Maternal and Child Health Program MOA Ministry of Agriculture MOF Ministry of Finance MOH Ministry of Health NCD Nonconimunicable disease OECD Organization for Economic Cooperation and Development PRC People's Republic of Chinia SOE State-owned enterprise SPC State Planning Commission SSB State Statistical Bureau TCM Traditional Chinese Medicine TFR Total fertility rate THC Township health centers (middle level of the rural three-tier health system, between village clinic and county hospital) U5MR Under-five mortality rate UNICEF United Nations Children's Fund WHO World Health Organization Glossary This glossary provides definitions of some of the key terms used in this report.
    [Show full text]
  • Global Health Threats and Fashioning out Effective Responses to Them
    Foreword by Yanzhong Huang Throughout recorded history, disease has consistently accounted for the greatest proportion of human morbidity and mortality, far surpassing war as a threat to human life. In the post-Cold War era, the threats to the health of populations from infectious diseases have actually increased, as diseases do not respect territorial borders and the burgeoning global activities make national borders increasingly porous. The anthrax attacks of 2001 and the recent SARS epidemic only highlight the importance of health as a national security or foreign policy issue. As threats to the health of populations gain prominence on the public policy agenda, decision makers face a host of thorny questions. Should a comprehensive strategy for biological security emphasize improvement in international public health? What is the best approach to engage the public sector and the pharmaceutical industry in building our biodefense? What roles should be played by the international organizations such as the World Health Organization to ensure maximum protection from infectious diseases with minimal disruption? To effectively address these concerns, policy makers and scholars alike must transcend traditional models of inter-state conflict and develop new tools of analysis in assessing the nature of global health threats and fashioning out effective responses to them. Against this background, the Whitehead School of Diplomacy launches its Center for Global Health Studies, which will examine global health issues from a foreign policy and national security perspective. Among its functions, the Center will develop coursework, curricula and symposia to train leaders, practitioners, and policy makers. Bringing together public, private and academic partners, the Center will serve as a think tank and resource center on issues relating to health policy, development, and international security.
    [Show full text]
  • Vol. 2 No. 31 Jul. 31, 2020
    Vol. 2 No. 31 Jul. 31, 2020 Preplanned Studies Burden of Acute Viral Hepatitis — China, 1990−2019 579 Supervised Analysis of Hepatitis C Virus RNA-Positive Case Reporting in County-Level Hospitals — China, 2013−2018 587 Recollection Progress Towards Hepatitis A Control and Prevention Through 2019: the National Immunization Program of China 591 Control of Chronic Hepatitis B in China: Perspective of Diagnosis and Treatment 596 Profiles Qiyong Liu, China CDC’s Chief Expert of Vector Control 601 Notifiable Infectious Diseases Reports Reported Cases and Deaths of National Notifiable Infectious Diseases — China, June, 2020 603 China CDC Weekly Editorial Board Editor-in-Chief George F. Gao Deputy Editor-in-Chief Liming Li Gabriel M Leung Zijian Feng Executive Editor Feng Tan Members of the Editorial Board Xiangsheng Chen Xiaoyou Chen Zhuo Chen (USA) Xianbin Cong Gangqiang Ding Xiaoping Dong Mengjie Han Guangxue He Xi Jin Biao Kan Haidong Kan Qun Li Tao Li Zhongjie Li Min Liu Qiyong Liu Jinxing Lu Huiming Luo Huilai Ma Jiaqi Ma Jun Ma Ron Moolenaar (USA) Daxin Ni Lance Rodewald (USA) RJ Simonds (USA) Ruitai Shao Yiming Shao Xiaoming Shi Yuelong Shu Xu Su Chengye Sun Dianjun Sun Hongqiang Sun Quanfu Sun Xin Sun Jinling Tang Kanglin Wan Huaqing Wang Linhong Wang Guizhen Wu Jing Wu Weiping Wu Xifeng Wu (USA) Zunyou Wu Fujie Xu (USA) Wenbo Xu Hong Yan Hongyan Yao Zundong Yin Hongjie Yu Shicheng Yu Xuejie Yu (USA) Jianzhong Zhan Liubo Zhang Rong Zhang Tiemei Zhang Wenhua Zhao Yanlin Zhao Zhijie Zheng (USA) Maigeng Zhou Xiaonong Zhou Baoping Zhu (USA)
    [Show full text]
  • East Asian Strategic Review 2005
    東アジア戦略概観2005英_0523 05.10.25 3:29 PM ページ91 Chapter 4 China— “Peaceful Rise” in Light and Shadow 東アジア戦略概観2005英_0523 05.10.25 3:29 PM ページ92 東アジア戦略概観2005英_0523 05.10.25 3:29 PM ページ93 he government of President Hu Jintao has entered its second year and has Tgradually begun to show its individuality. One typical example is its advocacy of China’s “peaceful rise” theory. Under this theory, his government seemed to position itself to sweep away the “China threat” theory externally and to create an environment conducive to economic development over the opposition of hard-liners internally. This was supposed to serve as a platform for promoting omnidirectional diplomacy, mainly for the purpose of spurring Chinese economic development. However, the government’s new policy line has been wavering in practice and, despite Jiang Zemin’s retirement from public life, a new era has yet to arrive. As it has in the past, China’s foreign policy stresses peace in the international arena. However, the biggest obstacle standing in the way of China’s peaceful rise is the Taiwan issue. Taiwan’s President Chen Shui-bian was reelected on a platform of a national referendum to adopt a new constitution. China views a new constitution, if adopted, as tantamount to independence from the mainland and warned that it would not rule out the use of force to prevent that from happening. It may be said that China is seeking effective measures to curb the growing movement within Taiwan that is attempting a process of “reverse Sinocization” to establish a Taiwanese identity.
    [Show full text]